What to Watch Out for at ASCO GI 2025: Key Abstracts for Community Oncologists
Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.
Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.
Of note, lung cancer incidence was higher among women younger than 65 compared with their male counterparts in 2021.
Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose methotrexate, according to results of a large, multicenter observational study.Glucarpidase (Voraxaze,…
OS benefits with tislelizumab plus chemotherapy were comparable between early and late responders in the phase 3 RATIONALE-306 study in patients with ESCC.
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
A Q and A with Dr. Cassandra Fritz from the WashU internal medicine program. The program is receiving a 2025 ACGME Barbara Ross-Lee, DO DEI…
Discover emerging themes and early-stage clinical oncology pipelines at the second AACR Oncology Industry Partnership event.
The 2025 American Cancer Society Annual Report Showed incidence rates are increasing for many cancer types and disparities remain regarding cancer mortality.
The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the…
Blood | 145 | 4 | January 2025
Featuring novel treatment strategies for lymphomas and kidney cancers, insights into inflammatory pain, and promising trial results for breast cancer and NSCLC